Your browser doesn't support javascript.
loading
A Review of Chronic Leukoencephalopathy among Survivors of Childhood Cancer.
Partap, Sonia; Russo, Suzanne; Esfahani, Bijan; Yeom, Kristen; Mazewski, Claire; Embry, Leanne; Wheeler, Greg; Ullrich, Nicole J; Bowers, Daniel C.
Afiliación
  • Partap S; Department of Neurology, Stanford University School of Medicine, Stanford, California.
  • Russo S; Department of Radiation Oncology, Case Western Reserve University School of Medicine, Cleveland, Ohio. Electronic address: suzanne.russo@UHhospitals.org.
  • Esfahani B; Stanford University School of Medicine, Stanford, California.
  • Yeom K; Department of Radiology, Stanford University School of Medicine, Stanford, California.
  • Mazewski C; Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, Georgia.
  • Embry L; Department of Pediatrics, University of Texas Health Science Center San Antonio, San Antonio, Texas.
  • Wheeler G; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Victoria, Australia.
  • Ullrich NJ; Department of Neurology, Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
  • Bowers DC; Department of Pediatrics, University of Texas Southwestern Medical School, Dallas, Texas.
Pediatr Neurol ; 101: 2-10, 2019 12.
Article en En | MEDLINE | ID: mdl-31047756
ABSTRACT
Currently, there are an estimated 400,000 long-term survivors of childhood cancer in the United States. Chronic leukoencephalopathy is a potential devastating late effect that can manifest as a range of neurological and neurocognitive sequelae. Survivors of the acute lymphocytic leukemia, central nervous system tumors, and stem cell transplant have frequently been exposed to cranial radiation, systemic and intrathecal chemotherapy, which places them at risk of developing chronic leukoencephalopathy. Defining leukoencephalopathy and its neuroimaging characteristics, the population of survivors at risk, its long-term consequences, and identifying prevention and intervention strategies can potentially mitigate the morbidity of these survivors. Better understanding of those at risk of leukoencephalopathy and its symptoms can lead to an improved quality of life for these cancer survivors.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Encéfalo / Leucoencefalopatías / Supervivientes de Cáncer Tipo de estudio: Prognostic_studies Aspecto: Patient_preference Límite: Child / Humans País/Región como asunto: America do norte Idioma: En Revista: Pediatr Neurol Asunto de la revista: NEUROLOGIA / PEDIATRIA Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calidad de Vida / Encéfalo / Leucoencefalopatías / Supervivientes de Cáncer Tipo de estudio: Prognostic_studies Aspecto: Patient_preference Límite: Child / Humans País/Región como asunto: America do norte Idioma: En Revista: Pediatr Neurol Asunto de la revista: NEUROLOGIA / PEDIATRIA Año: 2019 Tipo del documento: Article
...